Answers are grounded in this paper and cite their sources.
Percutaneous renal mass biopsy (RMB) remains a valuable method to provide a presurgical histopathologic diagnosis of renal masses, but it is an invasive procedure and is not always feasible. Accumulating data support the use of imaging features to predict histopathology of renal masses. Imaging may help address some of the inherent limitations of RMB, and in certain settings, a multimodal clinical approach may allow decreasing the need for RMB.
No takes yet. Share an insight, caveat, or question.
Leon et al. (2019) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: